Author: Yu Ke-Da
Publisher: Springer Publishing Company
ISSN: 0167-6806
Source: Breast Cancer Research and Treatment, Vol.122, Iss.3, 2010-08, pp. : 853-858
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Sex steroid hormones and their receptors such as estrogen receptor (ER) and progesterone receptor (PgR) have been widely studied for their roles in the etiology of breast cancer. To date, many studies have evaluated the association between a functional polymorphism in the PgR gene promoter (+331G>A, rs10895068) and breast cancer risk; however, the result is still ambiguous and inconclusive. In order to derive a more precise estimation of the association, a meta-analysis was performed in this study. By searching relevant literature, a total of 10 studies containing 13,702 cases and 14,726 controls (28,428 subjects in total) were identified and meta-analyzed. All the study subjects were Caucasian women. Crude odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of association in the codominant model, dominant model, and recessive model. Overall, no significant association between +331G>A polymorphism and breast cancer susceptibility was observed for AA versus GG (OR = 0.940, 95% CI: 0.566–1.562), GA versus GG (OR = 1.061, 95% CI: 0.888–1.267), AA + GA versus GG (OR = 1.074, 95% CI: 0.956–1.207), and AA versus GA + GG (OR = 0.951, 95% CI: 0.586–1.544). Sensitivity analysis was performed by limiting the meta-analysis to those studies fulfilling Hardy–Weinberg equilibrium, and the results were not materially altered in any genetic model. In conclusion, the present meta-analysis strongly suggests that +331G>A in the PgR gene is not associated with breast cancer risk.
Related content
By Liu Ting Chen Lilan Sun Xiangjun Wang You Li Shu Yin Xia Wang Xinran Ding Chenhuan Li He Di Wen
Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. :
By Yu Ke-Da
Breast Cancer Research and Treatment, Vol. 122, Iss. 2, 2010-07 ,pp. :
By Yao Lei Qiu Li-Xin Yu Lu Yang Zhen Yu Xia-Jia Zhong Yang Yu Long
Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. :